May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Nutra concentrated 60.43% of sales in Topical with a 30.51% month-over-month increase and 29.64% year-over-year growth, while Capsules held 39.57% share with an 11.44% MoM lift and 29.02% YoY gain; this split pushed the brand-wide YoY sales up 27.65% despite only a 3.36% YoY increase in average price to $42.82. The category skew toward Topical, combined with a 4th-place rank in Topical in British Columbia, indicates that May 2026 performance leaned on accelerated Topical velocity rather than broad-based pricing or mix expansion.
The sharper 30.51% MoM surge in Topical versus 11.44% in Capsules, alongside a 43.86 average price in Topical compared to 41.32 in Capsules, implies May 2026 growth was driven by higher-price, faster-accelerating items without over-reliance on discounting; this tilts positioning toward efficacy-focused use cases where Topical adoption is rising faster than ingestibles. Given 60.43% Topical share against 39.57% in Capsules and a Topical rank of 4 in British Columbia, Nutra’s near-term opportunity is to consolidate Topical gains while selectively nurturing Capsules to prevent over-concentration risk in a single category.
Competitive Landscape
Nutra sits at #4 in BC Topical for May 2026 with a 0-position year-over-year rank change and a 1-position slide from #3 in February 2026 to #4 in May 2026, while Proofly held #1 both year-over-year and currently as its sales grew 36.2%, and Wildflower climbed from #7 to #3 with 525.6% YoY growth, overtaking Nutra after Nutra dropped from #3 to #4 over the last three months; meanwhile, Stewart Farms advanced from #3 to #2 as Wildflower Canada fell from #2 to #5 with a 24.3% YoY sales decline. The pattern implies Nutra’s flat YoY rank at #4 coupled with a recent slip from #3 to #4 signals pressure from faster-rising peers and a need to counter momentum shifts concentrated between #2 and #4.

Notable Products
CBD/CBG 5:1 Sunbeam Capsules 30-Pack (3000mg CBD, 600mg CBG) led May 2026 with a 184.9% month-over-month surge and a jump into shared rank 3, while the Topical category’s CBD/CBG 24k Gold Magnesium + Hyaluronic Acid Transdermal Spray (500mg CBD, 50mg CBG, 60ml) fell 62.1% to rank 8. The lead SKU’s rise outpaced the 68.9% gain of CBD/CBG 5:1 Harmony Blend Relief Stick (1000mg CBD, 200mg CBG) at rank 5 and contrasted with a 57.0% drop for CBD/CBG/CBN 1:1:1 Balance Beam Capsules 30-Pack (600mg CBD, 600mg CBG, 600mg CBN) at rank 7. With four of the top eight belonging to Capsules and showing both a 184.9% spike and declines of 14.4% and 57.0%, the mix points to Nutra consolidating growth around targeted capsule formulations while pruning or repositioning slower mixed-cannabinoid lines.
CBD Peppermint Lavender + MAG + Hyaluronic Acid Balm (3000mg CBD) maintained rank 1 with 32.1% MoM growth and $67,383 in sales, as CBD Hemp Isolate Capsules 30-Pack (3000mg CBD) rose 16.0% to rank 2. Meanwhile, CBD Isolate Capsules 15-Pack (1500mg CBD) slid 14.4% at rank 4 and CBD Isolate Capsules 60-Pack (6000mg CBD) dipped 5.2% at rank 3. The combination of a 32.1% leader in Topical and mixed results from isolate capsules implies Nutra is finding higher velocity in benefit-led formats over pure-strength laddering.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







